INFECTIONS CAUSED BY ANTIBIOTICresistant
|
|
- Florence Patrick
- 5 years ago
- Views:
Transcription
1 ORIGINAL CONTRIBUTION Antibiotic Prescription Rates for Acute Respiratory Tract Infections in US Ambulatory Settings Carlos G. Grijalva, MD, MPH J. Pekka Nuorti, MD, DSc Marie R. Griffin, MD, MPH See also Patient Page. Context During the 199s, antibiotic prescriptions for acute respiratory tract infection (ARTI) decreased in the United States. The sustainability of those changes is unknown. Objective To assess trends in antibiotic prescriptions for ARTI. Design, Setting, and Participants The National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey data () were used to examine trends in antibiotic prescription rates by antibiotic indication and class. Annual survey data and census denominators were combined in 2-year intervals for rate calculations. Main Outcome Measures National annual visit rates and antibiotic prescription rates for ARTI, including otitis media (OM) and non-arti. Results Among children younger than 5 years, annual ARTI visit rates decreased by 17% (95% confidence interval [CI], 9%-24%), from 1883 per 1 population in to 156 per 1 population in, primarily due to a 33% (95% CI, 22%-43%) decrease in OM visit rates (95 to 634 per 1 population, respectively). This decrease was accompanied by a 36% (95% CI, 26%-45%) decrease in ARTI-associated antibiotic prescriptions (1216 to 779 per 1 population). Among persons aged 5 years or older, ARTI visit rates remained stable but associated antibiotic prescription rates decreased by 18% (95% CI, 6%-29%), from 178 to 146 per 1 population. Antibiotic prescription rates for non-om ARTI for which antibiotics are rarely indicated decreased by 41% (95% CI, 22%-55%) and 24% (95% CI, 1%- 37%) among persons younger than 5 years and 5 years or older, respectively. Overall, ARTI-associated prescription rates for penicillin, cephalosporin, and sulfonamide/ tetracycline decreased. Prescription rates for azithromycin increased and it became the most commonly prescribed macrolide for ARTI and OM (1% of OM visits). Among adults, quinolone prescriptions increased. Conclusions Overall antibiotic prescription rates for ARTI decreased, associated with fewer OM visits in children younger than 5 years and with fewer prescriptions for ARTI for which antibiotics are rarely indicated. However, prescription rates for broadspectrum antibiotics increased significantly. JAMA. 29;32(7): INFECTIONS CAUSED BY ANTIBIOTICresistant microorganisms are associated with increased morbidity, mortality, and substantial economic burden. 1 Antibiotic use creates selective pressure for the emergence of antibiotic-resistant bacteria. 2-4 During the past decade, a variety of US initiatives have promoted the judicious use of antibiotics, 5,6 particularly for acute respiratory tract infection (ARTI), which is a common cause of health care encounters and antibiotic prescriptions, especially in young children. In the late 199s, antibiotic prescription rates in both children and adults decreased, 7-1 but these decreases were initially accompanied by increased prescription of broad-spectrum antibiotics Interventions not directly targeting antibacterial use may also have reduced antibiotic prescriptions and limited the spread of antibiotic resistance. For example, routine US infant immunization with a 7-valent pneumococcal conjugate vaccine (PCV-7) resulted in decreases in rates of invasive disease due to antibiotic-resistant Streptococcus pneumoniae. 12 Data from the Centers for Disease Control and Prevention s (CDC s) laboratory and population-based surveillance indicate that decreases in pneumococcal isolates resistant to penicillin, sulfonamides, and selected cephalosporins has been sustained, but the proportion of erythromycin-resistant pneumococcus increased after the initial decreases. 13 In the late 199s, increasing rates of macrolide-resistant invasive pneumococcal disease were temporally associated Author Affiliations: Departments of Preventive Medicine (Drs Grijalva and Griffin) and Medicine (Dr Griffin), Vanderbilt University School of Medicine, Nashville, Tennessee; and The National Center for Immunization and RespiratoryDiseases,CentersforDiseaseControlandPrevention, Atlanta, Georgia (Dr Nuorti). Corresponding Author: Carlos G. Grijalva, MD, MPH, Department of Preventive Medicine, Vanderbilt University School of Medicine, 15 21st Ave, Ste 26, The Village at Vanderbilt, Nashville, TN (carlos.grijalva@vanderbilt.edu). 758 JAMA, August 19, 29 Vol 32, No. 7 (Reprinted) 29 American Medical Association. All rights reserved.
2 with increasing use of macrolides, especially azithromycin. 14 Recent measurements of antibiotic prescription patterns in the United States are unavailable. This article assesses national trends in antibiotic prescriptions for ARTI in ambulatory settings. METHODS Sources of Information We analyzed annual data from the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS) between 1995 and. The NAMCS gathers data on a nationally representative sample of visits to office-based physicians engaged in direct patient care, whereas the NHAMCS collects data on a representative sample of visits to hospital-based emergency departments and outpatient clinics. These surveys record patient demographics, symptoms, procedures, diagnoses, and prescribed medications for a systematic sample of visits. During the study period, physician participation rates in NAMCS ranged from 59% to 73%, and the unweighted item nonresponse rates were typically 5% or less. 15 Rates of hospital participation in NHAMCS ranged from 9% to 98% and the unweighted item nonresponse rates were typically 5% or less. 16 Upto3diagnosespervisitarerecorded in the NAMCS and NHAMCS databases, using International Classification of Diseases, NinthRevision, ClinicalModification (ICD-9-CM) codes. The ARTI visits included those patients with any listed diagnosis of otitis media (OM), bronchitis, bronchiolitis, pneumonia, sinusitis, pharyngitis, tonsillitis, laryngitis, tracheitis, nasopharyngitis, andmastoiditis(icd-9-cm codes 381.x-383.x, 46.x-466.x, 48.x- 487.x, 49.x). Rates were also calculated forom, themostcommonreasonforphysician visits and antibiotic prescriptions in young children 8 (ICD-9-CM codes 381.x-382.x).Forspecificanalyses,wealso defined2mutuallyexclusivegroups:arti for which antibiotics are often indicated (OM, mastoiditis, sinusitis, pharyngitis, tonsillitis, and nonviral pneumonia) ; and ARTI for which antibiotics are rarely indicated (acute nasopharyngitis, laryngitis, unspecified upper respiratory tract infection, bronchitis, bronchiolitis, viral pneumonia, and influenza) We also exploredtheconcurrentpresenceofcommon non-arti diseases that could result in an antibiotic prescription, such as urinary tract infections (ICD-9-CM codes 599., 595., 595.9) and soft tissue infections (ICD-9-CM codes 68.x-682.x). 8,2 Antibiotic classes included in the study were penicillins, cephalosporins, sulfonamides, tetracyclines, macrolides (including azalides), lincosamides, and quinolones. Antibiotic prescriptions were identified using the National Drug Code directory, generic names, drug names, and the Multum classification of therapeutic classes. 15,16 Visits that resulted in the prescription of at least 2 antibiotic classes contributed 1 observation to each class and rates of specific antibiotic prescriptions during ARTI visits were estimated. Because use of some antibiotics was rare, estimates for sulfonamides and tetracyclines, and lincosamides and macrolides were analyzed together. Quinolone exposures were too rare to estimate rates for children. Separate estimates were obtained for azithromycin, amoxicillin, and amoxicillin/clavulanic acid. Azithromycin exposures were too rare to estimate prescription rates for OM for children younger than 5 years until Statistical Analysis For a comprehensive assessment of US ambulatory settings, the NAMCS and NHAMCS data were combined and to obtain robust estimates, annual survey data were combined in 2-year intervals. 8 All reported estimates were based on at least 3 unweighted observations and relative standard errors of less than 3%. 15,16 Because children younger than 5 years had the highest visit rates for ARTI and antibiotic prescriptions 8 and early activities promoting judicious use of antibiotics were primarily focused on them, 21 our analyses were stratified into 2 groups: children younger than 5 years and persons 5 years or older. To assess differential effects of age and the aging of the US population, 22 persons 5 years or older were further stratified (5-17 years, years, 5-64 years, years, and 8 years). Survey data were weighted to produce national estimates, with weights accounting for selection probabilities, adjustment for nonresponse, population ratio adjustments, and weight smoothing. 15,16 Weighted observations represented rate numerators and denominators were obtained from the US Census Bureau. For each 2-year period, the population was calculated by averaging the 2-year population estimates. To estimate average annual rates and rate ratios (RRs), we fitted Poisson regression models to the survey data. Census population estimates for each period and age groups provided an approximation to the person-time for each period and were distributed according to the aggregated weight factor of the national surveys, representing the offset term in the models. 22,23 Our models included terms for age, time, and an age time interaction term and accounted for the complex survey sampling design. Per our planned analyses, we compared the first ( ) with the most recent ( ) observation period, using RRs estimated by using linear predictors from the regression models. Rate differences and their 95% confidence intervals (CIs) were also calculated. We also assessed changes in prescribing practices by calculating the proportion of visits that resulted in antibiotic prescriptions. 8 Proportions were estimated accounting for the survey design and trends in proportions were tested by using weighted least square regressions. 8 All reported P values were 2-tailed and accounted for the complex survey design. P.5 indicated statistical significance. Data were analyzed by using SAS version 9.1 (SAS Institute, Cary, North Carolina) and Stata version 1. (StataCorp LP, College Station, Texas) survey packages. This study was considered exempt from review by the institutional review boards of Vanderbilt University and the CDC. 29 American Medical Association. All rights reserved. (Reprinted) JAMA, August 19, 29 Vol 32, No
3 RESULTS Visit Characteristics During the 12-year period, the surveys estimated 6.2 billion ambulatory visits in the United States. Overall, 59% of patients were female and 84% were white. Approximately 82% of visits were to physician practices, 8% to hospitalbased outpatient clinics, and 1% to emergency departments. Overall, antibiotics were prescribed in 13% of all ambulatory visits. The ARTI visits accounted for 1% of all visits and for 44% of all antibiotic prescribing. Children younger than 5 years accounted for 9% of all visits and 34% of their visits were ARTI-associated. In this group, antibiotics were prescribed in 26% of all visits and in 56% of ARTI visits. Persons 5 years or older accounted for 91% of all visits and ARTI represented 8% of their visits. In this group, antibiotics were prescribed in 12% of all visits and in 58% of ARTI visits. Table 1. US Rate Differences and Rate Ratios of Ambulatory Visits and Antibiotic Prescriptions, a Visits by Age, y Rate Difference Rate Ratio All visits ( 149 to 117) 1.8 (.97 to 1.21) (174 to 541) 1.17 (1.8 to 1.26) (129 to 455) 1.11 (1.5 to 1.17) (615 to 165) 1.22 (1.16 to 1.28) (122 to 1841) 1.25 (1.18 to 1.32) (186 to 2156) 1.26 (1.18 to 1.35) ARTI visits ( 461 to 171).83 (.76 to.91) ( 84 to 29).94 (.83 to 1.6) ( 4 to 14).93 (.82 to 1.7) (2 to 83) 1.19 (1.1 to 1.4) ( 66 to 46).95 (.77 to 1.16) ( 111 to 22).81 (.61 to 1.8) Non-ARTI visits (547 to 91) 1.25 (1.19 to 1.31) (317 to 449) 1.24 (1.2 to 1.28) (273 to 331) 1.12 (1.11 to 1.13) (755 to 836) 1.22 (1.21 to 1.23) (1373 to 1498) 1.26 (1.25 to 1.27) (157 to 1743) 1.28 (1.27 to 1.3) Antibiotics in all visits ( 551 to 281).73 (.64 to.82) ( 112 to 5).9 (.8 to 1.1) ( 25 to 49) 1.3 (.93 to 1.13) (3 to 141) 1.23 (1.8 to 1.39) (87 to 274) 1.38 (1.19 to 1.59) (27 to 37) 1.28 (1.5 to 1.57) Antibiotics in ARTI visits ( 542 to 315).64 (.55 to.74) ( 127 to 58).7 (.6 to.82) ( 45 to 1).83 (.7 to.99) ( 6 to 54) 1.17 (.95 to 1.45) ( 42 to 3).93 (.71 to 1.21) ( 77 to 4).71 (.5 to 1.2) Antibiotics in non-arti visits ( 47 to 84) 1.4 (.86 to 1.25) (2 to 8) 1.16 (1.1 to 1.34) (12 to 61) 1.15 (1.5 to 1.26) (22 to 16) 1.25 (1.9 to 1.44) (15 to 279) 1.58 (1.33 to 1.88) (77 to 347) 1.51 (1.2 to 1.89) Abbreviations: ARTI, acute respiratory tract infection; CI, confidence interval. a Data are from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. Rates are average annual rates for each period (per 1 population). Children Younger Than 5 Years ARTI Visits. Overall annual visit rates were 4773 per 1 population in and remained stable during the study period. Although ARTI-associated visit rates decreased by 17% (RR,.83; 95% CI, ), non-arti visit rates increased by 25% (RR, 1.25; 95% CI, ) (TABLE 1 and FIGURE 1). Concomitant conditions as a possible reason for antibiotic prescriptions associated with ARTI visits such as urinary tract infections (.26% of ARTI visits) or soft tissue infections (.6%) were uncommon. ARTI-Associated Antibiotic Prescriptions. Annual antibiotic prescription rates decreased by 27% or 424 per 1 children (95% CI, ). This decrease was due to a 36% (RR,.64; 95% CI, ) reduction in ARTI-associated antibiotic prescriptions. Antibiotic prescription rates for non-arti visits remained stable (Table 1). The overall proportion of visits resulting in antibiotic prescriptions decreased from 33% in to 22% in (P =.8), due to reductions from 65% to 5% (P=.1) in the proportion of ARTI visits resulting in antibiotics. The proportion of non-arti visits resulting in antibiotic prescriptions remained stable (P=.16). In physician practices, the proportion of ARTI visits that resulted in antibiotics decreased from 65% to 48% (P=.9); no significant decreases were observed in emergency department visits (from 63% to 55%, P=.11) or in hospital-based outpatient clinics (from 6% to 54%, P=.12). Rates of ARTI visits resulting in penicillin prescriptions decreased by 31% (TABLE 2). Amoxicillin/clavulanic acid prescription rates remained stable, 76 JAMA, August 19, 29 Vol 32, No. 7 (Reprinted) 29 American Medical Association. All rights reserved.
4 whereas amoxicillin prescription rates decreased by 37%. Cephalosporin and sulfonamide/tetracycline prescription rates decreased by 47% and 91%, respectively. Azithromycin prescription rates for ARTI increased 9-fold from to, but overall prescription rates for macrolides/lincosamides remained stable (Table 2), mainly due to decreases in erythromycin use (data not shown because of unreliable estimates during last periods). Otitis Media. Annual OM rates decreased by 33% from 95 to 634 per 1 children from to, respectively (RR,.67; 95% CI, ). Similarly, rates of antibiotic prescriptions for OM decreased by 36% from 76 to 484 per 1 children (RR,.64; 95% CI, ). The proportion of OM visits that resulted in antibiotic prescriptions remained approximately 8% throughout the study years (P=.14) (FIGURE 2). Penicillin prescription rates for OM decreased from 39 to 37 per 1 children (RR,.79; 95% CI, ), amoxicillin rates decreased from 326 to 233 per 1 children (RR,.71; 95% CI, ), and amoxicillin/ clavulanic acid prescription rates remained stable. Cephalosporin prescription rates decreased from 211 to 13 per 1 children in (RR,.49; 95% CI, ). Sulfonamide/ tetracycline prescription rates decreased from 143 to 11 per 1 children (RR,.8; 95% CI,.4-.15), whereas macrolide/lincosamide prescription rates remained stable. Azithromycin prescription rates remained stable from to Figure 1. National US Rates of Ambulatory Visits and Antibiotic Prescriptions, Visit rates 6 5 All ambulatory visits ARTI visits Non-ARTI visits <5 Years 5 Years Visit Rate per 1 Population Antibiotic prescription rates 18 All ambulatory visits ARTI visits Non-ARTI visits Antibiotic Visits per 1 Population ARTI indicates acute respiratory tract infection. Error bars represent 95% confidence intervals. Data are from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. Rates are average annual rates for each period. 29 American Medical Association. All rights reserved. (Reprinted) JAMA, August 19, 29 Vol 32, No
5 Table 2. US Rates, Rate Differences, and Rate Ratios of Antibiotic Prescriptions During ARTI Visits for Persons Younger Than 5 Years and 5 Years or Older a (RR, 1.1; 95% CI, ); in, it was the most prescribed macrolide for OM with 65 (95% CI, 46-9) prescriptions per 1 children (approximately 1% of OM visits). Non-OM ARTI. Overall, rates of antibiotic prescriptions associated with non-om ARTI visits decreased by 35% (RR,.65; 95% CI, ). Rates of non-om ARTI for which antibiotics are often indicated, rates of antibiotic prescription associated with these visits, and the proportion of these visits resulting in an antibiotic prescription did not change significantly throughout the study years (Figure 2). Rates of ARTI visits for which antibiotics are rarely indicated remained stable, whereas associated antibiotic prescription rates decreased by 41% (RR,.59; 95% CI, ). The proportion of these non-om ARTI visits resulting in antibiotic prescriptions also decreased from 41% in to 23% in (P=.4) (Figure 2). Persons Aged 5 Years or Older ARTI Visits. Overall annual visit rates increased by 19% from 3154 to 3758 per 1 population (RR, 1.19; 95% CI, Rate Difference Rate Ratio 5 Years Penicillins ( 274 to 121).69 (.58 to.81) Amoxicillin ( 26 to 139).63 (.53 to.75) Amoxicillin/clavulanic acid ( 19 to 55) 1.13 (.76 to 1.68) Cephalosporins ( 192 to 88).53 (.39 to.72) Macrolides/lincosamides ( 41 to 57) 1. (.74 to 1.36) Azithromycin (64 to 23) 8.78 (4.99 to 15.44) Sulfonamides/tetracyclines ( 193 to 174).9 (.5 to.15) 5 Years Penicillins ( 42 to 25).58 (.48 to.69) Amoxicillin ( 37 to 24).51 (.42 to.63) Amoxicillin/clavulanic acid (1 to 7) 1.44 (1.8 to 1.93) Cephalosporins ( 2 to 1).59 (.47 to.74) Macrolides/lincosamides ( to 23) 1.22 (1.1 to 1.48) Azithromycin (22 to 44) 6.2 (4.63 to 8.3) Sulfonamides/tetracyclines ( 9 to 3).53 (.35 to.81) Quinolones (11 to 24) 5.39 (3.95 to 7.36) Abbreviations: ARTI, acute respiratory tract infection; CI, confidence interval. a Data are from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. Rates are average annual rates for each period (per 1 population). 1.23). This was primarily due to a 21% increase in non-arti visit rates (RR, 1.21; 95% CI, ). ARTI rates remained stable and similar changes were observed in the age-stratified analyses (Table 1 and Figure 1). Although decreases in rates of OM and related antibiotic prescriptions in this age group were similar to those among children younger than 5 years, these rates were substantially lower (Figure 2). As with children, concomitant conditions during an ARTI visit that could result in antibiotic prescriptions such as urinary tract infections (.66%) or soft tissue infections (.15%) were uncommon. ARTI-Associated Antibiotic Prescriptions. Although overall antibiotic prescription rates remained stable among persons 5 years or older, the stratified analysis showed significant increases among persons 5 years or older. Overall antibiotic prescriptions associated with ARTI visits decreased by 18% (RR,.82; 95% CI, ) but significant decreases occurred only among persons younger than 5 years. Non-ARTI visit associated antibiotic prescriptions increased in all groups 5 years or older (Table 1). Overall, about 12% of all visits for persons 5 years or older consistently resulted in antibiotic prescriptions. The proportion of ARTI visits that resulted in antibiotic prescriptions was 63% in and 54% in (P=.7). The proportion of non-arti visits resulting in antibiotic prescriptions remained stable (P=.79). In physician practices, the proportion of ARTI visits that resulted in antibiotic prescriptions among persons 5 years or older decreased from 63% to 52% (P=.2), whereas no significant changes were observed in emergency department visits (from 63% to 64%, P=.51) or in hospital-based outpatient clinics (from 61% to 6%, P=.88). Overall rates of ARTI visits resulting in penicillin prescriptions decreased by 42% (Table 2). Amoxicillin prescription rates decreased by 49%, whereas amoxicillin/clavulanic acid rates increased by 44%. Cephalosporin prescription rates decreased by 41% and sulfonamide/tetracycline rates decreased by 47%. Macrolide/ lincosamide prescription rates increased by 22%, mainly due to a 6-fold increase in azithromycin prescription rates. Quinolone prescription rates increased 5-fold. Similar changes in prescriptions of antibiotic classes were observed across age groups (TABLE 3). Non-OM ARTI. Overall antibiotic prescription rates for non-om ARTI among persons 5 years or older decreased by 15% (RR,.85; 95% CI, ), due primarily to decreases in antibiotic prescriptions for ARTI for which antibiotics are rarely indicated. Rates of non-om ARTI visits for which antibiotics are often indicated showed a nonsignificant increase (RR, 1.12%; 95% CI, ) and rates of antibiotic prescription associated with these visits remained stable. The proportion of these visits resulting in antibiotic prescriptions decreased by 13% (P=.4) and was 59% in (Figure 2). Rates of non-om ARTI visits for which antibiotics are rarely indicated had a nonsignificant decrease of 9% (RR,.91; 95% CI,.8-1.4), whereas antibiotic prescription rates associated with 762 JAMA, August 19, 29 Vol 32, No. 7 (Reprinted) 29 American Medical Association. All rights reserved.
6 these visits decreased by 24% (RR,.76; 95% CI,.63-.9). The proportion of these visits that resulted in an antibiotic prescription did not change significantly and was 48% in (Figure 2). COMMENT Our analysis of 12 years of national ambulatory survey data showed sustained decreases in ARTI-associated antibiotic prescription rates. These decreases were primarily observed in physician practices and were associated with a decrease in both OM visits (children 5 years) and antibiotic prescriptions associated with ARTI for which antibiotics are rarely indicated (all age groups). Although these observations are en- Figure 2. US Rates of Otitis Media and Non Otitis Media ARTI Visits, Antibiotic Prescriptions, and Proportion of Visits Resulting in Antibiotic Prescriptions, Visit rates Visit Rate per 1 Population Otitis media (antibiotics often indicated) (antibiotics rarely indicated) <5 Years 5 Years Antibiotic prescription rates Antibiotic Visits per 1 Population Otitis media (antibiotics often indicated) (antibiotics rarely indicated) Antibiotic prescriptions during visits Proportion of Visits With Antibiotics, % Otitis media (antibiotics often indicated) (antibiotics rarely indicated) ARTI indicates acute respiratory tract infection. Error bars represent 95% confidence intervals. for which antibiotics are often indicated include mastoiditis, sinusitis, pharyngitis, tonsillitis, and nonviral pneumonia. for which antibiotics are rarely indicated include acute nasopharyngitis, laryngitis, unspecified upper respiratory tract infection, bronchitis, bronchiolitis, viral pneumonia, and influenza. Data are from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Medical Care Survey. Rates are average annual rates for each period. 29 American Medical Association. All rights reserved. (Reprinted) JAMA, August 19, 29 Vol 32, No
7 couraging, the prescription of broadspectrum antibiotics, namely azithromycin and quinolones, increased substantially during the study period. The decreases observed in antibiotic prescriptions in children younger than 5 years were largely related to decreases in OM visit rates. Moreover, our findings indicate that by the end of the study period, the Healthy People 21 target of 56 antibiotic courses prescribed for ear infections per 1 children younger than 5 years was already reached. 24 However, the proportion of OM visits that resulted in antibiotic prescriptions remained stable, suggesting that clinicians practices for antibiotic prescribing given a diagnosis of OM did not change. Although the American Academy of Pediatrics practice guidelines for the management of OM were updated in early 24 to encourage the initial observation of nonsevere OM cases in selected children (ie, watchful waiting ), 25,26 the largest observed decreases preceded these recommendations. Moreover, recent evidence suggests low adherence to the updated guidelines. 27 Although visit rates for non-om ARTI for which antibiotics are rarely indicated remained stable in children younger than 5 years, rates of antibiotic prescriptions Table 3. US Rates, Rate Differences, and Rate Ratios of Antibiotic Prescriptions During ARTI Visits for Each Period a Antibiotics by Age, y associated with these visits decreased. Furthermore, theproportionofvisitsthat resulted in antibiotic prescriptions decreased. Similarly, amongpersons5years or older, visit rates for ARTI for which antibiotics are rarely indicated remained stable and there was a significant reduction in antibiotic prescriptions associated with these visits. These findings suggest improvements in antibiotic prescribing practices and previous observed decreases in antibiotic prescriptions for these conditions were sustained through. 9,1,28,29 Starting in the mid-199s, the CDC, several state and local health departments, and other organizations launched interventions to promote appropriate antibiotic prescriptions. 6 In 1995, the CDC launched the Campaign for Appropriate Antibiotic Use in the Community and working with the American Academy of Pediatrics and the American Academy of Family Physicians, this initiative led to the publication of The Principles for appropriate use of antibiotics for pediatric upper respiratory tract infections. 6 Furthermore, a number of projects launched at local or state levels have shown significant improvements in antibiotic prescribing, including controlled interventions in Denver (), Boston/Seattle ( ), Tennessee (), Wisconsin (1997), and Alaska (-), among others. 6 The CDC also launched the media campaign Get Smart: Know When Antibiotics Work in 23. Although the specific reasons for decreasing ARTI visit rates cannot be established, several explanations could be hypothesized. First, the application of stricter diagnostic criteria for specific ARTI, a central component of the campaigns promoting the judicious use of antibiotics, could have increased the threshold to diagnose these conditions, 21 resulting in subsequent reductions in antibiotic prescriptions. 3 Second, parents might be less likely to bring their children to a clinician for mild ARTI. 31 Health care encounters can be prevented by educating parents to identify and relieve ear pain in their children. 26,32 Moreover, the CDC Get Smart campaign was asso- Rate Difference Rate Ratio Penicillins ( 274 to 121).69 (.58 to.81) ( 91 to 39).64 (.52 to.8) ( 36 to 21).53 (.43 to.66) ( 21 to 4).7 (.44 to 1.1) ( 32 to 3).51 (.28 to.94) ( 25 to 5).53 (.24 to 1.16) Cephalosporins ( 192 to 88).53 (.39 to.72) ( 36 to 12).6 (.44 to.82) ( 17 to 5).59 (.43 to.82) ( 18 to 2).59 (.37 to.94) ( 22 to ).65 (.42 to 1.1) ( 34 to 4).5 (.28 to.91) Macrolides/lincosamides ( 41 to 57) 1. (.74 to 1.36) ( 12 to 18) 1.2 (.78 to 1.33) ( 1 to 28) 1.25 (.99 to 1.59) (4 to 45) 1.51 (1.9 to 2.8) ( 13 to 41) 1.17 (.73 to 1.88) ( 23 to 44).99 (.5 to 1.95) Sulfonamides/tetracyclines ( 193 to 174).9 (.5 to.15) ( 17 to 1).37 (.15 to.93) ( 9 to 1).53 (.3 to.93) ( 2 to 12) 1.34 (.75 to 2.4) ( 13 to 1).36 (.14 to.9) ( 22 to 3).23 (.6 to.86) Quinolones (7 to 23) 4.63 (2.88 to 7.43) (1 to 49) 4.56 (2.49 to 8.36) (13 to 65) 6.41 (3.28 to 12.52) (1 to 7) 4.58 (2.18 to 9.65) Abbreviations: ARTI, acute respiratory tract infection; CI, confidence interval. a Data are from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. Rates are average annual rates for each period (per 1 population). 764 JAMA, August 19, 29 Vol 32, No. 7 (Reprinted) 29 American Medical Association. All rights reserved.
8 ciated with decreases in ARTI visits and related antibiotic prescriptions in Colorado. 33 Third, routine childhood immunization with PCV-7 since reduced the incidence of both OM and pneumonia during the study period. The decreases in OM visits we report herein are consistent with other estimates of the effect of this intervention Influenza vaccines, recommended for use among young children since 24 and among all children 6 months or older since 28, could further reduce the incidence of ARTI and associated antibiotic prescriptions. Although ARTI-associated prescriptionsformostantibioticclassesdecreased, prescription of selected macrolides and quinolonesincreasedsubstantially. Inthe early 199s, the recognition of the role of atypical microorganisms in ARTI and the emergence of penicillin-resistant bacteria led to the recommendation of macrolides as a first-line empirical treatment for community-acquired pneumonia. 3,39 Macrolides have since been used widely to treat ARTI 3,4 and, although decreases in invasive pneumococcal disease due to nonsusceptible pneumococci were documented after PCV-7 introduction, concerns remain about the increasing use of azithromycin in the United States. 7,9,12 Young children are commonly colonized with pneumococcus. Azithromycin is a bacteriostatic antibiotic and the least potentmacrolideagainstpneumococcus. Its longhalf-lifeofapproximately3daysmay result in prolonged exposure of bacteria to relatively inactive concentrations of the antibiotic and selection of resistant strains. 41,42 Although the ease of administration is an advantage, a recent meta-analysis of randomized and quasirandomized controlled trials showed that azithromycin efficacy against bronchitis or pneumonia was not better than amoxicillinoramoxicillin/clavulanicacid. 43 Recent guidelines for community-acquired pneumonia in ambulatory adults suggest that macrolide monotherapy should be restricted to selected patients (ie, previously healthy and without risk factors for drug-resistant S pneumoniae). 44 After introduction of PCV-7 in the United States, the incidence of pneumococcal disease due to nonvaccine serotypesincreased.theseincreaseshavebeen mostnotableforserotype19a,atypethat frequently is resistant to multiple antibiotics. 45 Increasing use of antibiotics, in particular selected macrolides, may contribute to the emergence of these antibiotic-resistantnonvaccineserotypes. Increases in disease due to antibioticresistant serotype 19A were reported among Alaskan Native, Bedouin, 46 and South Korean children, populations in which azithromycin is widely used, although the latter 2 groups were not routinely immunized with PCV-7. Interestingly, no increases in disease due to serotype 19A have been described among White Mountain Apache, 47 a population exposed to PCV-7 and in which azithromycin use is approved only for the treatment of sexually transmitted diseases and for children with documented penicillin allergy. 48 Our findings indicate that azithromycinprescriptionratesincreased substantially during recent years. The effects of these increases on the emergence of antibiotic-resistant pneumococcal serotypes not covered by PCV-7 remain to be determined. We also observed increasing prescription rates for quinolones for ARTI in persons 5 years or older. Increases in quinolone prescriptions and disease caused by quinolone-resistant bacteria have been reported in the United States and internationally Although the reported proportion of pneumococcal disease that is quinolone-resistant is small ( 1.8%), 5 the increasing trends are of concern and warrant monitoring. 49,5 Ourresultshadafewstudylimitations. First, we used ICD-9-CM codes to identifyartiandcouldnotconfirmdiagnoses or appropriateness of antibiotics prescribed.second,althoughourstudyevaluated antibiotic prescriptions, the adherence to these regimens is unknown. Additional antibiotic prescriptions or changes made by telephone were not captured by the surveys. Third, available information did not allow the distinction between initial and follow-up visits throughoutthestudyyears. Theinclusion of follow-up visits when no new antibioticwasprescribedwouldresultinanun- derestimation of the proportion of ARTI that resulted in an antibiotic prescription. Fourth, surveyparticipationrateshavedecreased and required adjustments in weighting strategies over time. Nevertheless, national survey data provided consistent information to assess changes in antibioticprescriptionpatterns. Fifth, federal institutions such as the Veterans Affairs ambulatory services are not included in the national surveys. Antibiotic use leads to the emergence of antibiotic-resistant bacteria. 2 Although prescriptions for most classes of antibiotics decreased, the prescription of quinolones and azithromycin increased. The potential role of these increases on the emergence of antibioticresistant microorganisms, in particular S pneumoniae, has been described. 2,3,14,52 Our results indicate that overall antibiotic prescription rates have decreased significantly. These changes coincided with efforts to reduce inappropriate antibiotic prescribing and the initiation of routine infant immunization with pneumococcal conjugate vaccine. Further efforts to improve antibiotic selection are needed. Author Contributions: Dr Grijalva had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Grijalva, Nuorti, Griffin. Acquisition of data: Grijalva. Analysis and interpretation of data: Grijalva, Nuorti, Griffin. Drafting of the manuscript: Grijalva. Critical revision of the manuscript for important intellectual content: Grijalva, Nuorti, Griffin. Statistical analysis: Grijalva. Obtained funding: Grijalva, Griffin. Administrative, technical, or material support: Nuorti, Griffin. Financial Disclosures: Drs Grijalva and Griffin reported receiving lecture fees and negotiating potential research support from Wyeth. Dr Griffin reported receiving grant support from MedImmune and Pfizer. Dr Nuorti reported no disclosures. Funding/Support: This study was funded by the Centers for Disease Control and Prevention (CDC) through Cooperative Agreements with the Association for Prevention Teaching and Research (TS-1392 and TS-1454). Dr Grijalva is supported by a CDC career development award (K1 CI163). Role of the Sponsor: An investigator from the CDC participated in the design and conduct of the study; in the analysis and interpretation of the data; and in the preparation, review, and approval of the manuscript. Disclaimer: The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the CDC. Additional Contributions: We thank CDC investigators Cynthia G. Whitney, MD, MPH, and Lauri A. Hicks, DO, MPH, for critical, noncompensated review of the manuscript. 29 American Medical Association. All rights reserved. (Reprinted) JAMA, August 19, 29 Vol 32, No
9 REFERENCES 1. Spellberg B, Guidos R, Gilbert D, et al; Infectious Diseases Society of America. The epidemic of antibioticresistant infections. Clin Infect Dis. 28;46(2): Besser RE. Antimicrobial prescribing in the United States: good news, bad news. Ann Intern Med. 23; 138(7): Klugman KP, Lonks JR. Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis. 25; 11(6): Lieberman JM. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance. Pediatr Infect Dis J. 23;22(12): Centers for Disease Control and Prevention. Get Smart: Know When Antibiotics Work. Accessed December 4, Weissman J, Besser RE. Promoting appropriate antibiotic use for pediatric patients. Semin Pediatr Infect Dis. 24;15(1): Finkelstein JA, Stille C, Nordin J, et al. Reduction in antibiotic use among US children, -. Pediatrics. 23;112(3 pt 1): McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 22;287(23): Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, Ann Intern Med. 23; 138(7): Roumie CL, Halasa NB, Grijalva CG, et al. Trends in antibiotic prescribing for adults in the United States. J Gen Intern Med. 25;2(8): McCaig LF, Besser RE, Hughes JM. Antimicrobial drug prescription in ambulatory care settings, United States, Emerg Infect Dis. 23; 9(4): Kyaw MH, Lynfield R, Schaffner W, et al; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. ; 354(14): Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs): surveillance reports. /survreports.htm. Accessed June 3, Hyde TB, Gay K, Stephens DS, et al; Active Bacterial Core Surveillance/Emerging Infections Program Network. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA. 21; 286(15): National Center for Health Statistics. Ambulatory Health Care Data: NAMCS description. http: // Accessed June 2, National Center for Health Statistics. Ambulatory Health Care Data: NHAMCS description. http: // Accessed June 2, Jacobs RF. Judicious use of antibiotics for common pediatric respiratory infections. Pediatr Infect Dis J. ;19(9): Dowell SF, Schwartz B, Phillips WR; The Pediatric URI Consensus Team. Appropriate use of antibiotics for URIs in children: part I, otitis media and acute sinusitis. Am Fam Physician. ;58(5): , Dowell SF, Schwartz B, Phillips WR; The Pediatric URI Consensus Team. Appropriate use of antibiotics for URIs in children: part II, cough, pharyngitis and the common cold. Am Fam Physician. ; 58(6): , Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA. 23;289(6): Dowell SF, Marcy SM, Phillips WR, et al. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics. ;11(1)(suppl): US Census Bureau. Population estimates: data sets. Accessed January 5, Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 24;292(11): Healthy People Accessed July 19, American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 24; 113(5): Finkelstein JA, Stille CJ, Rifas-Shiman SL, Goldmann D. Watchful waiting for acute otitis media: are parents and physicians ready? Pediatrics. 25;115 (6): Vernacchio L, Vezina RM, Mitchell AA. Management of acute otitis media by primary care physicians. Pediatrics. 27;12(2): Halasa NB, Griffin MR, Zhu Y, Edwards KM. Decreased number of antibiotic prescriptions in officebased settings from 1993 to 1999 in children less than five years of age. Pediatr Infect Dis J. 22;21 (11): Linder JA, Bates DW, Platt R. Antivirals and antibiotics for influenza in the United States, Pharmacoepidemiol Drug Saf. 25;14(8): Finkelstein JA, Huang SS, Kleinman K, et al. Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics. 28; 121(1):e15-e Cosby JL, Francis N, Butler CC. The role of evidence in the decline of antibiotic use for common respiratory infections in primary care. Lancet Infect Dis. 27;7(11): McWilliams DB, Jacobson RM, Van Houten HK, et al. A program of anticipatory guidance for the prevention of emergency department visits for ear pain. Arch Pediatr Adolesc Med. 28;162(2): Gonzales R, Corbett KK, Wong S, et al. Get smart Colorado : impact of a mass media campaign to improve community antibiotic use. Med Care. 28; 46(6): Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. ; 118(3): Poehling KA, Szilagyi PG, Grijalva CG, et al. Reduction of frequent otitis media and pressureequalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 27;119(4): Zhou F, Kyaw MH, Shefer A, et al. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med. 27;161(12): Zhou F, Shefer A, Kong Y, Nuorti JP. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 24. Pediatrics. 28;121(2): Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 27; 369(9568): Niederman MS, Bass JB Jr, Campbell GD, et al; American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis. 1993; 148(5): Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother. 22;5(suppl S1): Doern GV. Macrolide and ketolide resistance with Streptococcus pneumoniae. Med Clin North Am. ; 9(6): McKenna S, Evans G; Canadian Infectious Disease Society Antimicrobial Agents Committee. Macrolides: a Canadian Infectious Disease Society position paper. Can J Infect Dis. 21;12(4): Panpanich R, Lerttrakarnnon P, Laopaiboon M. Azithromycin for acute lower respiratory tract infections. Cochrane Database Syst Rev. 28;(1): CD Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 27;44(suppl 2):S27-S Moore MR, Gertz RE Jr, Woodbury RL, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 25. JInfect Dis. 28;197(7): Dagan R, Givon-Lavi N, Leibovitz E, et al. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. JInfect Dis. 29;199(6): Lacapa R, Bliss SJ, Larzelere-Hinton F, et al. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Clin Infect Dis. 28;47(4): Black S. Changing epidemiology of invasive pneumococcal disease: a complicated story. Clin Infect Dis. 28;47(4): Linder JA, Huang ES, Steinman MA, et al. Fluoroquinolone prescribing in the United States: 1995 to 22. Am J Med. 25;118(3): Karchmer AW. Increased antibiotic resistancein respiratory tract pathogens: PROTEKT US an update. Clin Infect Dis. 24;39(suppl 3):S142-S von Gottberg A, Klugman KP, Cohen C, et al; Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA). Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa. Lancet. 28; 371(9618): Chancey S, Zhou X, Stephens D. Macrolide efflux system encoded by mefe/mel(msra) in Streptococcus pneumoniae is induced by 14- and 15- membered, but not 16-membered macrolides. Poster presented at: Sixth International Symposium on Pneumococci and Pneumococcal Diseases; June 1, 28; Reykjavik, Iceland. Poster P JAMA, August 19, 29 Vol 32, No. 7 (Reprinted) 29 American Medical Association. All rights reserved.
Antimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016
Antimicrobial Stewardship in the Outpatient Setting ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016 Abbreviations AMS - Antimicrobial Stewardship Program OP - Outpatient OPS - Outpatient Setting
More informationMeasure Information Form
Release Notes: Measure Information Form Version 3.0b **NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE** Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form
More information3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats
Antibiotics --When Less is More Ralph Gonzales, MD, MSPH Associate Dean, Clinical Innovation School of Medicine VP, Clinical Innovation, UCSF Health Most Urgent Threats Serious Threats Multidrug-Resistant
More informationAntimicrobial Prescribing for Upper Respiratory Infections and Its Effect on Return Visits
182 March 2009 Family Medicine Clinical Research and Methods Antimicrobial Prescribing for Upper Respiratory Infections and Its Effect on Return Visits John Li, MPH; Anindya De, PhD; Kathy Ketchum, RPh,
More informationImproving Human Antibiotic Use in the Community Get Smart: Know When Antibiotics Work
Improving Human Antibiotic Use in the Community Get Smart: Know When Antibiotics Work Lauri Hicks, DO Director, Office of Antibiotic Stewardship Medical Director, Get Smart: Know When Antibiotics Work
More informationPhysician Rating: ( 23 Votes ) Rate This Article:
From Medscape Infectious Diseases Conquering Antibiotic Overuse An Expert Interview With the CDC Laura A. Stokowski, RN, MS Authors and Disclosures Posted: 11/30/2010 Physician Rating: ( 23 Votes ) Rate
More informationSupplementary Online Content
Supplementary Online Content Gerber JS, Prasad PA, Fiks AG, et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians:
More informationObjective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest
Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial
More informationOutpatient Antimicrobial Stewardship. Jeffrey S Gerber, MD, PhD Division of Infectious Diseases The Children s Hospital of Philadelphia
Outpatient Antimicrobial Stewardship Jeffrey S Gerber, MD, PhD Division of Infectious Diseases The Children s Hospital of Philadelphia Overview The case for outpatient antimicrobial stewardship Interventions
More information10/9/2017. Evidence-Based Interventions to Reduce Inappropriate Prescription of Antibiotics. Prescribing for Respiratory Tract Infections
Evidence-Based Interventions to Reduce Inappropriate Prescription of Antibiotics Ann Thomas, MD, MPH Oregon Public Health Division Prescribing for Respiratory Tract Infections Antibiotic use is primary
More informationAntimicrobial Drug Prescriptions in Ambulatory Care Settings, United States, Linda F. McCaig,* Richard E. Besser,* and James M.
Antimicrobial Drug Prescriptions in Ambulatory Care Settings, United States, 1992 2000 Linda F. McCaig,* Richard E. Besser,* and James M. Hughes* During the 1990s, as antimicrobial resistance increased
More informationControl emergence of drug-resistant. Reduce costs
...PRESENTATIONS... Guidelines for the Management of Community-Acquired Pneumonia Richard E. Chaisson, MD Presentation Summary Guidelines for the treatment of community-acquired pneumonia (CAP) have been
More informationANTIBIOTIC UTILIZATION FOR ACUTE RESPIRATORY TRACT INFECTIONS IN UNITED STATES EMERGENCY DEPARTMENTS
AAC Accepts, published online ahead of print on 16 December 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.02039-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 ANTIBIOTIC
More informationUpdate on CDC Antibiotic Stewardship Activities
National Center for Emerging and Zoonotic Infectious Diseases Update on CDC Antibiotic Stewardship Activities CAPT Lauri Hicks, DO CAPT Arjun Srinivasan, MD Division of Healthcare Quality Promotion National
More informationCompliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings
Compliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings Jasmanda H. Wu, Ph.D., 1 David H. Howard, Ph.D., 2 John E. McGowan, Jr.,
More informationTreatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance
Journal of Antimicrobial Chemotherapy (2008) 61, 1162 1168 doi:10.1093/jac/dkn073 Advance Access publication 29 February 2008 Treatment costs associated with community-acquired pneumonia by community level
More informationUnited States Outpatient Antibiotic Prescribing and Goal Setting
National Center for Emerging and Zoonotic Infectious Diseases United States Outpatient Antibiotic Prescribing and Goal Setting Katherine Fleming-Dutra, MD Office of Antibiotic Stewardship Division of Healthcare
More informationAntibiotic resistance has become one of the most pressing
CLINICAL Variation in US Outpatient Antibiotic Prescribing Quality Measures According to Health Plan and Geography Rebecca M. Roberts, MS; Lauri A. Hicks, DO; and Monina Bartoces, PhD Antibiotic resistance
More informationAntibiotic Stewardship in Human Health- Progress and Opportunities
National Center for Emerging and Zoonotic Infectious Diseases Antibiotic Stewardship in Human Health- Progress and Opportunities CAPT Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship Division
More informationThe World Health Organization has referred to. Antibiotic Resistance: The Iowa Experience DRUG UTILIZATION. Nancy Bell, RPh
DRUG UTILIZATION Antibiotic Resistance: The Iowa Experience Nancy Bell, RPh Background: In the past 10 years, the number of strains of Streptococcus pneumoniae and other common respiratory pathogens that
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form
Last Updated: Version 3.2a NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form Organization Set Measure ID#
More informationARTICLE. Antibiotic Prescribing by Primary Care Physicians for Children With Upper Respiratory Tract Infections
ARTICLE Antibiotic Prescribing by Primary Care Physicians for Children With Upper Respiratory Tract Infections David R. Nash, MD; Jeffrey Harman, PhD; Ellen R. Wald, MD; Kelly J. Kelleher, MD Objectives:
More informationAccording to a recent National ... PRESENTATION...
... PRESENTATION... in Treating Respiratory Tract Infections in an Age of Antibiotic Resistance Miguel Mogyoros, MD Presentation Summary Managing respiratory tract infections (RTIs) presents many challenges
More informationCommunity-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018
Community-Associated C. difficile Infection: Think Outside the Hospital Maria Bye, MPH Epidemiologist Maria.Bye@state.mn.us 651-201-4085 May 1, 2018 Clostridium difficile Clostridium difficile Clostridium
More informationINCREASING RESISTANCE TO ANTIBIotics
ORIGINAL CONTRIBUTION Changes in Antibiotic Prescribing for Children After a Community-wide Campaign Joseph F. Perz, DrPH Allen S. Craig, MD Christopher S. Coffey, PhD Daniel M. Jorgensen, MD, MPH Edward
More informationAntibiotic use among children in British Columbia, Canada
Journal of Antimicrobial Chemotherapy (2006) 58, 830 839 doi:10.1093/jac/dkl275 Advance Access publication 18 August 2006 Antibiotic use among children in British Columbia, Canada Fawziah Marra 1,2 *,
More informationCore Elements of Outpatient Antibiotic Stewardship Implementing Antibiotic Stewardship Into Your Outpatient Practice
National Center for Emerging and Zoonotic Infectious Diseases Core Elements of Outpatient Antibiotic Stewardship Implementing Antibiotic Stewardship Into Your Outpatient Practice Katherine Fleming-Dutra,
More informationVaccination as a potential strategy to combat Antimicrobial Resistance in the elderly
Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption
More informationTrends in Outpatient Antibiotic Use in 3 Health Plans
Trends in Outpatient Antibiotic Use in 3 Health Plans Jonathan A. Finkelstein, MD, MPH, a, b Marsha A. Raebel, PharmD, c, d James D. Nordin, MD, MPH, e Matthew Lakoma, MPH, b Jessica G. Young, PhD b OBJECTIVES:
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES:
More informationThe Pennsylvania State University. The Graduate School. College of Medicine ASSESSING AND COMPARING ANTIBIOTIC THERAPY TRENDS FOR CHILDREN
The Pennsylvania State University The Graduate School College of Medicine ASSESSING AND COMPARING ANTIBIOTIC THERAPY TRENDS FOR CHILDREN WITH ACUTE OTITIS MEDIA FROM 2005 TO 2014 IN U.S A Thesis in Public
More informationSeasonality of Antibiotic-Resistant Streptococcus pneumoniae That Causes Acute Otitis Media: A Clue for an Antibiotic-Restriction Policy?
MAJOR ARTICLE Seasonality of Antibiotic-Resistant Streptococcus pneumoniae That Causes Acute Otitis Media: A Clue for an Antibiotic-Restriction Policy? Ron Dagan, 1 Galia Barkai, 1 Noga Givon-Lavi, 1 Amir
More informationManagement of Acute Otitis Media After Publication of the 2004 AAP and AAFP Clinical Practice Guideline
Management of Acute Otitis Media After Publication of the 2004 AAP and AAFP Clinical Practice Guideline WHAT S KNOWN ON THIS SUBJECT: The 2004 AAP and AAFP clinical practice guideline on AOM allowed for
More informationWho is the Antimicrobial Steward?
Who is the Antimicrobial Steward? J. Njeri Wainaina, MD FACP Assistant Professor of Medicine Division of Infectious Diseases and Section of Perioperative Medicine Disclosures None 1 Objectives Highlight
More informationPneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center
Pneumonia considerations 2017 Galia Rahav Infectious diseases unit Sheba medical center Sir William Osler (1849 1919) "Father of modern medicine Pneumonia: The old man's friend The captain of the men of
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority
Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate
More informationThe Big Picture: Using Antibiotic Use and Surveillance Data to Better Inform Stewardship in Healthcare Settings
The Big Picture: Using Antibiotic Use and Surveillance Data to Better Inform Stewardship in Healthcare Settings Becky Roberts, MS Get Smart: Know When Antibiotics Work Office of Antibiotic Stewardship
More informationCritical Appraisal Topic. Antibiotic Duration in Acute Otitis Media in Children. Carissa Schatz, BSN, RN, FNP-s. University of Mary
Running head: ANTIBIOTIC DURATION IN AOM 1 Critical Appraisal Topic Antibiotic Duration in Acute Otitis Media in Children Carissa Schatz, BSN, RN, FNP-s University of Mary 2 Evidence-Based Practice: Critical
More informationANTIMICROBIAL STEWARDSHIP FOR AMBULATORY CARE SETTINGS
ANTIMICROBIAL STEWARDSHIP FOR AMBULATORY CARE SETTINGS Jeffrey S Gerber, MD, PhD Children s Hospital of Philadelphia University of Pennsylvania School of Medicine DISCLOSURE STATEMENT I have no conflicts
More informationSeasonality of Antibiotic#Resistant Streptococcus pneumoniae That Causes Acute Otitis Media: A Clue for an Antibiotic#Restriction Policy?
Seasonality of Antibiotic#Resistant Streptococcus pneumoniae That Causes Acute Otitis Media: A Clue for an Antibiotic#Restriction Policy? The Harvard community has made this article openly available. Please
More informationModeling the Emergence of Multidrug Antibiotic Resistance
ISDC 2001 - Atlanta, USA Modeling the Emergence of Multidrug Antibiotic Resistance Jack Homer, Ph.D Homer Consulting James Jorgensen, Ph.D Prof. of Pathology & Medicine Univ. of Texas, San Antonio Kate
More informationMarc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium
AAC Accepts, published online ahead of print on April 0 Antimicrob. Agents Chemother. doi:./aac.0001- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationOutpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Acute Bacterial Rhinosinusitis
Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment
More informationRational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550
Rational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550 Sinusitis Upper respiratory tract infections (URI) Common cold
More information5/15/17. Core Elements of Outpatient Antibiotic Stewardship: Implementing Antibiotic Stewardship Into Your Outpatient Practice.
National Center for Emerging and Zoonotic Infectious Diseases Core Elements of Outpatient Antibiotic Stewardship: Implementing Antibiotic Stewardship Into Your Outpatient Practice Melinda Neuhauser, PharmD,
More informationBarriers to Intravenous Penicillin Use for Treatment of Nonmeningitis
JCM Accepts, published online ahead of print on 7 July 2010 J. Clin. Microbiol. doi:10.1128/jcm.01012-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Voluntary Only
Last Updated: Version 4.4a NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form Collected For: CMS Voluntary
More informationORIGINAL INVESTIGATION. Increasing Outpatient Fluoroquinolone Exposure Before Tuberculosis Diagnosis and Impact on Culture-Negative Disease
ORIGINAL INVESTIGATION Increasing Outpatient Fluoroquinolone Exposure Before Tuberculosis Diagnosis and Impact on Culture-Negative Disease Pinky D. Gaba, MD; Connie Haley, MD, MPH; Marie R. Griffin, MD,
More informationMDPH Antibiotic Resistance Program and the All-Payer Claims Data. Kerri Barton, MDPH Joy Vetter, Boston University, MDPH October 19, 2017
MDPH Antibiotic Resistance Program and the All-Payer Claims Data Kerri Barton, MDPH Joy Vetter, Boston University, MDPH October 19, 2017 Outline Massachusetts DPH antibiotic resistance work The Massachusetts
More informationAntimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS
Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives
More informationIDSA GUIDELINES COMMUNITY ACQUIRED PNEUMONIA
page 1 / 5 page 2 / 5 idsa guidelines community acquired pdf IDSA/ATS Guidelines for CAP in Adults CID 2007:44 (Suppl 2) S29 such as blood and sputum cultures. Conversely, these cultures may have a major
More informationBacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota
Bacterial Resistance of Respiratory Pathogens John C. Rotschafer, Pharm.D. University of Minnesota Antibiotic Misuse ~150 million courses of antibiotic prescribed by office based prescribers Estimated
More informationMost acute respiratory tract infections. Acute respiratory tract infection: A practice examines its antibiotic prescribing habits
Michael L. Grover, DO; Martina Mookadam, MD; Richard H. Rutkowski, MD; Allison M. Cullan, MD; Destin E. Hill, MD; David C. Patchett, DO; Esan O. Simon, MD; MariLynn Mulheron, NP; Brie N. Noble, BS Department
More informationQuality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction
Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process
More informationRace, Otitis Media, and Antibiotic Selection
ARTICLE Race, Otitis Media, and Antibiotic Selection AUTHORS: Katherine E. Fleming-Dutra, MD, a Daniel J. Shapiro, BA, b Lauri A. Hicks, DO, c Jeffrey S. Gerber, MD, PhD, d and Adam L. Hersh, MD, PhD e
More informationECHO: Management of URIs. Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018
ECHO: Management of URIs Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018 Infectious causes of URIs change over time Most ARIs are viral
More informationGeriatric Mental Health Partnership
Geriatric Mental Health Partnership September 8, 2017 First, let s test your knowledge about antibiotics http://www.cdc.gov/getsmart/community/about/quiz.html 2 Get Smart Antibiotics Quiz Antibiotics fight
More informationEVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK
EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK EPIDEMIOLOGY AND BACKGROUND Every year, more than 2 million people in the United States acquire antibiotic-resistant
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationAntimicrobial use in humans
Antimicrobial use in humans Ann Versporten Prof. Herman Goossens OIE Global Conference on the Responsible and Prudent Use of Antimicrobial Agents for Animals - 13 March 2013 - Ann.versporten@ua.ac.be Herman.goossens@uza.be
More informationAntibiotic Prescribing for Canadian Preschool Children: Evidence of Overprescribing for Viral Respiratory Infections
155 Antibiotic Prescribing for Canadian Preschool Children: Evidence of Overprescribing for Viral Respiratory Infections Elaine E. L. Wang, Thomas R. Einarson, James D. Kellner, and John M. Conly From
More informationPhysicians Knowledge of prescribing antibiotics for acute Upper Respiratory Tract Infection.
Physicians Knowledge of prescribing antibiotics for acute Upper Respiratory Tract Infection Awwad Alenezy 1, Fayez Alenezy 2, Al dhafeeri Obaid Manzel 3 and Basem M.M. Salama 1 1 Family and Community Medicine
More informationPredictors of the Diagnosis and Antibiotic Prescribing to Patients Presenting with Acute Respiratory Infections
Predictors of the Diagnosis and Antibiotic Prescribing to Patients Presenting with Acute Respiratory Infections BY RYAN JOERRES CAPSTONE COMMITTEE MEMBERS: DENNIS J. BAUMGARDNER, MD, AJAY K. SETHI, PH.D.,
More informationStudy of Fluoroquinolone Usage Sensitivity and Resistance Patterns
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2013, 5 (5):195-199 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationChallenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.
Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial
More informationANTIBIOTICS ARE THE MOST COMmon
ORIGINAL CONTRIBUTION Effect of an Outpatient Antimicrobial Stewardship Intervention on Broad-Spectrum Antibiotic Prescribing by Primary Care Pediatricians A Randomized Trial Jeffrey S. Gerber, MD, PhD
More informationAntibiotics Use And Concordance To Guidelines For Patients Hospitalized With Community Acquired Pneumonia (CAP)
Antibiotics Use And Concordance To Guidelines For Patients Hospitalized With Community Acquired Pneumonia (CAP) SF Teoh 1, Samsinah Hussain 1, CK Liam 2 1 Departments of Pharmacy, Faculty of Medicine,
More informationThe Three R s Rethink..Reduce..Rocephin
The Three R s Rethink..Reduce..Rocephin By: Alisa Cuff RN,BN,CIC and John Bautista B.Sc. (Chem), B.Sc.Pharm, M.Sc.Pharm IPAC National Conference 2017 Newfoundland and Labrador Regional Health Authorities
More informationPrescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children
Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children Prescribing Antimicrobials for Common Illnesses When treating common illnesses such as ear infections and strep throat,
More informationThe development of antibioticresistant
Appropriate Antimicrobial Prescribing: Approaches that Limit Antibiotic Resistance RICHARD COLGAN, M.D., University of Maryland School of Medicine, Baltimore, Maryland JOHN H. POWERS, M.D., National Institutes
More informationAntimicrobial Stewardship in Ambulatory Care
Antimicrobial Stewardship in Ambulatory Care Nila Suntharam, M.D. May 5, 2017 Dr. Suntharam indicated no potential conflict of interest to this presentation. She does not intend to discuss any unapproved/investigative
More informationEffect of Establishment of Treatment Guidelines on Antibiotic Prescription Pattern for Children with Upper Respiratory Tract Infection
Effect of Establishment of Treatment Guidelines on Antibiotic Prescription Pattern for Children with Upper Respiratory Tract Infection Ghada. M. Khalil 1&2, Abdullah A Alghasham 3, Yasser F Abdelraheem
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority
Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate Use of Healthcare 2019 COLLECTION
More informationDoes Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?
Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and
More informationCMS Antibiotic Stewardship Initiative
CMS Antibiotic Stewardship Initiative Mary Fermazin, MD, MPA Chief Medical Officer Vice President, Health Policy and Quality Measurement Health Services Advisory Group (HSAG) March 11, 2017 Disclosure
More informationCME/CE QUIZ CME/CE QUESTIONS. a) 20% b) 22% c) 34% d) 35% b) Susceptible and resistant strains of typical respiratory
CME/CE QUIZ CME/CE QUESTIONS Continuing Medical Education Accreditation This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for
More informationAntibiotic Stewardship in LTC What does this mean?
Antibiotic Stewardship in LTC What does this mean? Kieran Moore FCFP,FRCPC, Diane Lu CCFP KFLA Public Health Disclosure The findings and conclusions represent those of the presenter and may not necessarily
More informationOutpatient Antibiotic Use and Stewardship in Minnesota. Catherine Lexau, PhD, MPH, RN Epidemiologist Principal Emma Leof, MPH CSTE Fellow May 1, 2018
Outpatient Antibiotic Use and Stewardship in Minnesota Catherine Lexau, PhD, MPH, RN Epidemiologist Principal Emma Leof, MPH CSTE Fellow May 1, 2018 Agenda Outpatient Antibiotic Use Summary Measuring Antibiotic
More informationOutpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks Vapo Rub for Cold Symptoms
Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment
More informationOutpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks VapoRub
Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment
More informationANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS
ANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS PHM025D March 2016 Neha Maliwal Project Analyst ISBN: 1-62296-252-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationDoxycycline for strep pneumonia
Doxycycline for strep pneumonia Antibiotic Levofloxacin (Levaquin) 750 mg, 500 mg for the treatment of respiratory, skin, and urinary tract infections, user reviews and ratings. 14-12-1995 John G. Bartlett,
More informationOutpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks VapoRub
Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment
More informationResistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints
...PRESENTATIONS... Resistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints Angela B. Brueggemann, MS; and Gary V. Doern, PhD Presentation Summary Streptococcus pneumoniae
More informationCHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationThe Core Elements of Antibiotic Stewardship for Nursing Homes
The Core Elements of Antibiotic Stewardship for Nursing Homes APPENDIX B: Measures of Antibiotic Prescribing, Use and Outcomes National Center for Emerging and Zoonotic Infectious Diseases Division of
More informationEuropean Antibiotic Awareness Day
Initiating a pan-european health campaign - experiences from setting up the European Antibiotic Awareness Day Dr Ülla-Karin Nurm Head of Public Health Development Section, Public Health Capacity and Communication
More informationOutpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Acute Bacterial Rhinosinusitis
Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment
More informationVolume 2; Number 16 October 2008
Volume 2; Number 16 October 2008 What s new this month NHS Lincolnshire have launched a public information campaign designed to raise public awareness of the risks associated with the inappropriate use
More informationACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective
ACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective Antwerpen 8 november 2002 Yvan Valcke MD PhD AZ Maria Middelares Sint-Niklaas ACUTE EXACERBATIONS of COPD (AE-COPD) Treatment of AECB Role
More informationImpact of a Standardized Protocol to Address Outbreak of Methicillin-resistant
Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant Staphylococcus Aureus Skin Infections at a large, urban County Jail System Earl J. Goldstein, MD* Gladys Hradecky, RN* Gary
More informationMeasure Information Form Collected For: CMS Voluntary Only The Joint Commission - Retired
Measure Information Form Collected For: CMS Voluntary Only The Joint Commission - Retired Last Updated: Version 4.3a Measure Set: Pneumonia (PN) Set Measure I #: Performance Measure Name: lood Cultures
More informationBelgian National Antibiotic Awareness Campaigns
Belgian National Antibiotic Awareness Campaigns Herman Goossens, Stijn De Corte, Samuel Coenen University of Antwerp and BAPCOC Joris Mateusen, Sarah Tulkens Absoluut Belgium Belgian National Antibiotic
More informationOptimizing Clinical Diagnosis and Antibiotic Prescribing for Common Respiratory Tract Infections, Fanara Family Health Center- Rural Egypt
Sameh F. Ahmed, et al Optimizing Clinical Diagnosis and Antibiotic Prescribing 105 Optimizing Clinical Diagnosis and Antibiotic Prescribing for Common Respiratory Tract Infections, Fanara Family Health
More informationAn Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?
An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings? Dr. Andrew Morris Antimicrobial Stewardship ProgramMt. Sinai Hospital University Health Network amorris@mtsinai.on.ca andrew.morris@uhn.ca
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationCore Elements of Antibiotic Stewardship for Nursing Homes
Core Elements of Antibiotic Stewardship for Nursing Homes Nimalie D. Stone, MD, MS Medical Epidemiologist for LTC Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Antimicrobial
More information